CannaBrand loses client after NY Times article offends industry

Image is everything. Just ask one of Colorado’s largest marketing companies.

The New York Times Style section published an article on Friday about rebranding the Colorado cannabis industry. The Colorado cannabis industry responded over the weekend in the form of angry posts on social media.

Cannabrand, the marijuana marketing company featured in the article, stated their intention to create a more upscale consumer cannabis experience. Industry members and activists sounded off about the lack of respect for how far they have come. After hearing about the criticisms over the weekend, the branding company’s dispensary client, MiNDFUL, heeded the outcry and dumped the company on Sunday.

Mindful CEO, Meg Sanders, issued a statement on Facebook:

MiNDFUL has parted with Cannabrand due to recent statements they have made that clearly conflict with our company values. We understand that these comments were hurtful and insulting to the industry and to the many that have fought so hard for years in the name of patient rights and safe access. We remain committed to serving our community, patients and customers with dignity and compassion.

Sanders confirmed through a company representative that the statement is accurate, but declined to comment further. Mindful — formerly known as Gaia, a dispensary chain with three locations in Colorado — took part in the article as a company trying to overhaul their image with the help of Cannabrand. Unfortunately, some of the comments made by Cannabrand co-owners Olivia Mannix and Jennifer DeFalco rubbed Sanders’ colleagues and customers the wrong way.

“I do take issue with a lot of what is said in this article,” wrote Kim Sidwell, owner of Cannabis Camera, and a long-time photographer for the industry. She goes on to explain that the stereotypes spoken about were real when she started her business in 2009, but have since changed.

What exactly did the CannaBrand co-owners say to get Sidwell and others so heated? Here are some quotes that riled.

“We’re weeding out the stoners,” said Olivia Mannix. “We want to show the world that normal, professional, successful people consume cannabis.”

Dispensaries still “look like underground abortion clinics,” Ms. Mannix said. Advertisements are full of “women with whipped cream straddling bongs,” Ms. [Jennifer] DeFalco said.

[NYTimes.com]

The article’s author did not help matters by using the word “pot” — ironically a word the article says not to use — in the title and making every Colorado marijuana dispensary sound like a tacky crack den. When Marijuana.com asked Sidwell for a few real-life examples of what dispensaries in Colorado look like, she happily obliged.

The two pictures below are the waiting room and inside of Terrapin Care Station, a dispensary in Boulder serving both retail and medical users. The featured image at the top of this article is the inside of Groundswell Cannabis Boutique, a medical-only dispensary in Denver.

Terrapin Care Station MMJ Dispensary- Boulder, CO

Terrapin Care Station, Boulder, CO- Inside

Marijuana.com contacted Mannix and DeFalco to get their response to the backlash from their remarks. While they declined to comment on the client loss, they provided a statement by email regarding the response to the article.

“We’ve received a broad range of feedback from across the country on the NY Times piece from people who felt that the article resonated with them, and others who didn’t see eye to eye.

We highly support the normalization of cannabis and are pushing for the advancement of legalization cross-nationally. We are aiming to open up the demographic of the cannabis consumer so that people of all walks of life are no longer afraid to identify themselves as cannabis users.”

Sidwell pointed out in her Facebook post that she has met both women before and believes their heads are in the right place. She says that her problem is with people making the industry look bad in order to make themselves look good.

“We already have enough enemies out there working to demonize the industry.” Sidwell said. “The last thing we need is a group of new cannabis-professionals needlessly making the industry look bad in an effort to gain attention for their own agenda.”

This article was originally published by Marijuana.com.

Pennsylvania’s watered-down marijuana law a ‘bittersweet’ win

“Well, I would have preferred a perfect bill — and this is not a perfect bill,” Pennsylvania State Senator Daylin Leach said of S.B. 1182.

Also known as the Medical Cannabis Act, the bill cleared the upper chamber with a vote of 43-7. Support for the measure’s passage in the state House waned, however, as advocates debated whether it was really a win. Marijuana.com spoke with Leach by phone following the vote.

“It’ll provide an awful lot of help for a lot of people and it also provides a system for the whole regime to grow over time.” said Leach, a supporter of better marijuana policy in Pennsylvania for decades. Not all medical marijuana advocates share his optimism.

An opinion piece on Philadelphia Magazine’s website lamented that the bill does not do enough, with former proponents disappointed about a change in the bill’s terms before passage.

“Pennsylvania’s amended SB 1182 is no longer a ‘medical marijuana’ bill but a ‘limited cannabis products’ bill,” Jay Lassiter says in the article. Lassiter is an HIV-positive medical marijuana activist from Cherry Hill, New Jersey.

An amendment passed before the bill came out of committee the day before the full Senate vote stripped 29 of about 40 qualifying conditions from the final draft, including glaucoma and HIV/AIDS. It also removed vaporization as an option. This after a previous amendment removed smoking as a way of medicating.

“This statement could not possibly have been made by anyone who has read the bill or understands the process.” Leach responded to Lassiter’s assessment that the bill is “an atrocious and cruel compromise made for political expediency.”

“To pass a bill setting up a protocol to grow, process and dispense marijuana to thousands of sick people in Pennsylvania, in a Republican controlled Senate, is nothing sort of a miracle.” Leach wrote. The legislative miracles, unfortunately, seem likely to end there.

The Marijuana Policy Project expressed ambivalence on the issue in two emails they sent to supporters before and after the vote. The national advocacy group’s first email followed the Senate Appropriations Committee voting 21-5 on September 23 to move the amended bill on to a full Senate vote.

“Unfortunately, even if the Senate passes the bill tomorrow, as it is expected to, a victory would be bittersweet.” MPP Director of State Policies, Karen O’Keefe wrote.

“In order to gain support from reluctant colleagues, SB 1182 was amended to strike the option of vaporizing cannabis (smoking was already forbidden) and to delete dozens of conditions, including spinal cord injury, Crohn’s disease, and rheumatoid arthritis,” she said. “For many patients, the immediate onset of smoked or vaporized cannabis is essential to providing relief: Nauseated patients can’t afford to wait an hour for their medicine to kick in.”

The email urged supporters to contact their senators and let them know that 85 percent of Pennsylvanians want a bill without the restrictions. Little hope remained, however, of changing the bill before the vote.

The next day all 23 Democrats and 20 of the 27 Republicans in the Senate voted in favor. A last ditch effort by Senator Lloyd Smucker, one of the seven voting against, would have caused even more anger.

The offered amendment aimed to remove all conditions except for seizures and epilepsy, aimed at sick children. This change would have brought the bill in line with what Republican Governor Tom Corbett said he would not veto. The Smucker Amendment failed by a vote of 42-8.

After the weakened bill passed the Senate, MPP again sent an email to supporters with bittersweet sentiments.

“Unfortunately, even if this legislation passes, it would leave most patients behind, and wouldn’t allow them to administer cannabis in the way that works best for them,” said MPP Deputy Director of State Policies Robert J Capecchi.

Only six session days remain in the state House before the legislative session ends. Republican Leadership has already expressed their intention to demand committee hearings, further complicating hopes of swift passage.

Looking toward the November elections offers some consolation for advocates. With Corbett down heavily in thegubernatorial polls against Democratic challenger Tom Wolf, it looks like marijuana advocates will have an ally in the Governor’s Mansion come January.

Leach told Marijuana.com that he intends to submit another medical marijuana bill should the session expire without House passage. He added that it might even be beneficial to pass the bill next year.

This article was originally published by Marijuana.com.

Pennsylvania senate OKs medical marijuana bill

Pennsylvania senators on Wednesday approved the state’s proposed medical marijuana act. The vote was 43-7 and the bill now goes to the state’s House of Representatives.

State Senators Daylin Leach, a Democrat, and Republican Mike Folmer introduced the bipartisan bill last November. But after amendments were added by the Law and Justice and Appropriations committees, the legislation is significantly watered down from its original language.

S.B. 1182 was formerly known as the “Governor Raymond Schafer Compassionate Use of Medical Cannabis Act.” Sponsors originally named it for the Pennsylvania governor who headed up President Richard Nixon’s National Commission on Marihuana and Drug Abuse. After the commission was formed in 1970, Schafer led the two-year study on the potential harm of marijuana use and concluded in a report that marijuana should be decriminalized nationwide.

“[T]he criminal law is too harsh a tool to apply to personal possession even in the effort to discourage use. It implies an overwhelming indictment of the behavior which we believe is not appropriate. The actual and potential harm of use of the drug is not great enough to justify intrusion by the criminal law into private behavior, a step which our society takes only ‘with the greatest reluctance.” – Marijuana, a Single of Misunderstanding, 1972

Nixon chose to ignore his own commissions recommendations and the report was buried. In another dismissal of the former governor’s effort to help produce reasonable drug laws, the name of the bill is now simply the “Medical Cannabis Act.”

It’s not hard to understand the name change, since the bill in its current form bears little resemblance to the emboldened efforts of Leach and Folmer. After the amended bill was voted out of the Appropriations Committee by a 21-5 margin, marijuana advocates bristled at the new law and voiced their opinion that it was not enough. In an email sent yesterday, MPP’s Director of State Policies, Karen O’Keefe, urged supporters to contact their representatives to voice concerns.

“Before tomorrow’s vote, let your senator know you stand with the 85% of Pennsylvanians who support allowing medical marijuana. Let him or her know that you want the legislature to enact a bill that doesn’t leave behind vast numbers of suffering patients, and that allows patients to administer medicine the way that works best for them.”

In addition to not allowing smoking of marijuana, a loss from a previous amendment, the bill now makes vaporization of marijuana off-limits as well. Senator Folmer reportedly claims that there were worries that people would use vaporization as a “sneaky” way of smoking.

The list of qualifying conditions for medical marijuana use was also pared down from 40 to 10. Cancer, epilepsy and seizures, ALS, cachexia, Parkinson’s, traumatic brain injury, MS, SCA, PTSD and severe fibromyalgia made the cut, while conditions like HIV/AIDS, Crohn’s disease, Alzheimer’s, rheumatoid arthritis and migraine headaches are out. Proponents of the change note that conditions can be added beginning on 2015 by petitioning the State Board of Medical Cannabis Licensing, which the law would create.

The bill now goes to the state representatives, where passage remains less certain. A well-placed source told Marijuana.com that the votes are there, but the Republican-controlled House doesn’t want to schedule a vote. By dragging their feet, House leadership may be able to run out the clock on this session, requiring that the bill start its journey over with a possible new cast of characters following the November elections.

This article was originally published by Marijuana.com.

Tommy Chong on dancing, aging and (of course) marijuana

“I’m Chong, man.”

That’s how Tommy Chong introduced himself to his new dancing partner and reintroduced himself to the world last Monday. A pre-recorded segment shown before Chong made his debut on Dancing With the Stars had him stumbling out of the back of a smoke-filled hippie van.

The green theme in his clothes — and everything else on stage — during his performance wasn’t subtle, but neither is Chong. He makes no secret about his goal of furthering the medical marijuana cause during his time on the show. Maybe it’s just for the easy puns, but ABC doesn’t have a problem with it.

“Absolutely the opposite.” Chong says when asked about backlash from representing marijuana on a “family” show. He explains that people have trouble demonizing the plant now that they are seeing how much it can help sick people. He claims his advocacy lets people understand him better.

“That pretty much shows everybody that I’m an actor playing a stoner, not a stoner playing an actor.”

Doctors diagnosed Chong with prostate cancer in 2012. A year later, after foregoing traditional chemotherapy in favor of high-dosage cannabis oil treatments, the comedian declared victory over the Big C. Along with a renewed faith in the healing powers of cannabis, Chong credits his cancer scare with being in better than average shape.

“I had to change my diet, then I had to get serious about working out. All that led to me being in shape enough so that I can dance with these young people.”

Despite being the oldest cast member at 76, Chong says he feels good. He compared being old on a dance show to having a big handicap in a golf tournament. Rehearsals, on the other hand, are no walk in the park.

“They go for 4 hours, 5 hours sometimes. It’s very intense.” says Chong. “Like a boot camp for dancers. We’re going into battle, so we have to be prepared.”

The wise gateway

Media and television continue to rely on stereotypes of lazy pot smokers as nothing more than comic relief. While Chong joins in on the marijuana gags and puns, a chat with him reveals that there is more to him than this. He says once people know that he is supporting medical marijuana openly on the show, that’s the first question they ask.

In this spirit, the NORML Advisory Board Member shared with Marijuana.com his new take on the “gateway drug” theory.

“Well, it is a gateway drug, but if you use the gate wisely it can open the door from a lot of addictions like cigarettes or alcohol, but especially cigarettes.” Chong says.

He went on to explain that when his was 20 years old, he smoked cigarettes. He decided to quit cigarettes, so every time he wanted a cigarette, he’d smoke a joint instead.

“It’s a gateway to good things.” Chong says after also telling about alcoholics who have given up their harmful addiction with the help of marijuana.

As for the specific benefits of marijuana, Chong feels overwhelmed by the sheer amount of information available. He says that when asked to justify his position, he often tells people to search “marijuana” on Google.

“You know, just Google it and find out the truth for yourself,” Chong says. “I can only talk on my experiences.”

DWTS- Week 2

Chong will be displaying his moves again Monday night doing a fast salsa with partner Peta. He promises more septuagenarian sex appeal for judge Julianne Hough who expressed pleasure at his smooth moves the first time around.

“Fast and sexy.” Chong says of tonight’s dance. “That’s the best way to describe it.”

When asked who he would most like to get high with among the judges, it was choreographer Bruno Tonioli who got the honors.

“Bruno’s the kind of guy who would try something and then ask you what it was.”

As for cast members, Tommy showed his fondness for his partner Peta Murgatroyd, saying that she’s the only cast member he wants to get high with.

Even though Chong came in 7th place last week with the judge’s scoring, pulling in a 27 out of 40, he says he not worried about his chances going forward.

“I’m not nervous because I know I have a lot of fan support and it’s my own personal belief that fan support is stronger than anything else.” Chong says confidently. “If you have the fan support, you can stay on the show for a long time and even win it.”

With multiple generations having fallen in love with Chong’s comedy and personality over the decades, he has plenty to be confident about. Whether those same fans will tune in to vote is another story, but if the audience and judge reaction to his first dance is any indicator, Chong’s quirky “sexy grandpa” is picking up new fans already.

This article was originally published by Marijuana.com.

Marijuana-themed dating sites on the rise

You’re out on a first date, everything went well at dinner and you’re standing at the door. That inevitable internal question arises.

No, not the one about whether to kiss your date goodnight, but about whether to ask them in for an after-dinner joint. Will your marijuana use be a shared interest or a night-ender?

Marijuana dating websites may be the answer to avoiding that awkward moment.

A quick search of Google leads to at least a half dozen other websites that promise to help in this area, the two most prominent being 420Singles.net and My420Mate.com

Marijuana and dating isn’t a completely new concept. Dating sites like OKCupid and Plenty of Fish offer browsing sections for people with marijuana as a similar interest. Other sites like eHarmony have articles online addressing the issue. Now it seems the market for dating cannabis lovers has grown large enough for its own websites.

According to Reuters, 420Singles.net boasts over 23,000 members while My420Mate.com has registered over 6,200. A medical marijuana user named Larry — a Vietnam War vet from Michigan — talked about how 420Singles made his current relationship much easier to find.

“She lives near me but we wouldn’t know about our shared medical marijuana use if we hadn’t connected on the site because no one discusses pot smoking in my circles,” [Larry] said.

While alcohol is the preferred social lubricant for most adults in America, a member of the site My420Mate.com identified as Corey from Missouri explained how the dating scene is different for marijuana users.

“Smokers come from all walks of life but they tend to chill back,” [Corey] says. “When I go out with buddies who get wasted on alcohol, it can be embarrassing. With my cannabis-smoking pals, we relax and let the creativity unroll.”

Both websites have reportedly had interest from investors and memberships are growing. Have you been looking for love on eHarmony or Match.com and just finding too many 420-intolerant dates? Maybe this is your chance for a change.

This article was originally published by Marijuana.com.

Warren Buffett wades into legal marijuana industry

The fourth-richest person in the world can see the great potential in legal marijuana — or at least one of his companies can.

Bloomberg reports that one of Warren Buffett‘s holdings is courting marijuana industry business. With the recent crunch for space to grow marijuana in Colorado, this could be another great example of Berkshire Hathaway’s chairman doing well by simply letting companies fill a market need.

Source: Cubic Designs via Bloomberg

About 1,000 fliers were sent in recent weeks from Cubic Designs, Inc. to marijuana-related businesses  in Colorado, Washington and California advertising “Double Your Growing Space” and featuring a picture of their mezzanine systems. Buffett added the eighteen year old New Berlin, WI company to Berkshire’s balance sheet last year.

Cubic Designs serves its market with design, engineering, fabrication and installation solutions, according to a press release put out after Berkshire subsidiary MiTek Industries acquired it in October.

“Through Cubic, MiTek is able to expand into new end markets with highly customized, tightly engineered, prefabricated structural steel products,” said Tom Manenti, Chairman and CEO of MiTek.

The mezzanine systems maximize warehouse space by setting up multiple levels for growing plants. The flier also featured a green cross on it, a symbol that has come to represent medical marijuana.

Buffett took over Berkshire Hathaway — formerly a textile manufacturing firm — in 1964 after seeing value in its assets. Since then he has grown the company to living legend status through wise investments in companies like See’s Candy, GEICO and Coca-Cola.

Berkshire’s stock is also famously exclusive due to Buffett’s aversion to stock splits. Splits create more shares to bring the price of each share down making it more accessible. Berkshire Class A common stock closed at $207,745 per share on Tuesday.

Shannon Shalchert, Cubic Designs’ Marketing Coordinator, declined to comment on this story, but she did speak to Bloomberg on Friday.

“We sold a few mezzanines into that market and decided internally, ‘Why don’t we do some marketing?’” Shalchert said.

Buffett gained a reputation over his decades of investing for having a hands-off approach where his investments are concerned so long as they are performing well.

Cubic Designs has also considered working with real estate agents. This strategy could score big in the growing market for finding and maximizing marijuana grow space. That would give Buffett another big win and bolster the viability of the legal marijuana industry to thousands of investors.

This article was originally published by Marijuana.com.

Philadelphia becomes the largest U.S. city to decriminalize marijuana

In June 2010, Philadelphia took a step toward decriminalizing marijuana with a program called SAM— standing for Small Amounts of non-medical Marijuana. Under this program, possession of less than 30 grams of marijuana was punished with arrest, a $200 fine and a three-hour class on drug abuse. As a form of decriminalization, this move failed horribly as arrests remained over 4,000 per year in Philadelphia.

This week, Mayor Michael Nutter finally agreed to sign the decriminalization bill that Philadelphia City Council passed 13-3 in May. Under the new ordinance, custodial arrest is finally off the table for small amounts of cannabis. Unlike other large cities that have taken steps toward decriminalization, this is the real deal.

One of those cities, Chicago, changed the law in 2012 so that mandatory arrest was not required for small amounts of marijuana. Instead, police have the option of writing a citation for $250 to $500. Unfortunately, according to a study by Roosevelt University, 93% of cases still end in arrest.

Philadelphia’s new law will fix this problem by making the penalties only financial with no chance of a criminal record. Instead, violations for possession of under 30 grams will be punished with a $25 civil fine. A Philadelphia-based news website reported in July that arrests for minor possession were still common– 264 in a month– even after the council’s vote. When the new bill passes, those arrests will drop to zero by law.

After holding out for several months, Nutter agreed on Monday to sign the bill before the September 11 deadline. The mayor finally gave in after City Council agreed to an extra $100 fine for public consumption of marijuana.

Councilman Jim Kenney, the bill’s author, pointed out the racial disparity that makes Nutter’s slow action surprising in a city where 82% of those arrested for simple possession are black, even though use rates are roughly the same among blacks and Caucasians.

“Marijuana possession and use has been decriminalized in Philadelphia for years … if you’re a white person,”Kenney told Mic. “If you’re a tailgater at an Eagle game, waiting for a Willie Nelson or Phish concert, or hanging out at a frat party, you’ll basically never be arrested for possession.”

While some cities around the country have decriminalized simple possession, Philadelphia is the largest by far– not counting Chicago’s weak attempt– with a population over 1.5 million. Philadelphia has the fifth largest population of any city in the United States. Even though Pennsylvania state does not have marijuana laws yet, Philadelphia has a larger population than several states that do such as Hawaii, Maine, New Hampshire and Rhode Island.

Philadelphia City Council will have to revise the bill with the agreed additions, but the signing is a foregone conclusion. Whether Nutter will continue to drag his feet, however, remains a mystery.

This article was originally published by Marijuana.com.

The Battle of Fife: Legal weed in Washington comes under fire

Mike Henery wanted to open a retail marijuana store. The Gig Harbor, WA resident thought that everything was going smoothly. He created a company– MMH, LLC– in December, 2013. Henery got the good news on May 1 that he would receive one of 17 licenses for retail marijuana outlets in Pierce County. The ganjapreneur then leased a location in Fife, WA to house his retail store. Only one thing stood in his way: the city of Fife.

When Henery went for a business license on July 7, the city’s Court Clerk refused his application. A week later, with no other relief available, Henery filed a complaint with the Pierce County Superior Court.

This isn’t a David and Goliath story. While MMH, LLC can be seen as the little guy, Fife isn’t much of a giant. The city has a population of only 9,333, making up 1.1% of Pierce County. In sharp contrast to Fife’s low profile are the cast of characters who would soon descend upon the legal drama.

Jennifer Combs of VSI Law Group filed Fife’s reply to MMH’s complaint on August 4.

Combs explained that the Fife City Council, by a 5-2 vote, passed Ordinance 1872 on July 8. This local law put a one-year moratorium on retail marijuana operations within the city limits, an area of about five and a half square miles.

Fife’s main argument was that its ordinance remains consistent with Washington’s state constitution. The city further argued that, if local bans were not permitted, the state’s marijuana law couldn’t be enforced since it is trumped by federal law. The second argument gave the case a higher profile.

Washington State Attorney General, Bob Ferguson, filed a motion on July 31 to intervene. He said in a press release that he was not arguing for either party. Instead, his argument would be to protect I-502, the ballot initiative that legalized marijuana for adult use in the state.

“This case presents a significant threat to the implementation of Initiative 502,” Ferguson said the day after he filed his brief with the court. “My office will continue to vigorously defend I-502 and uphold the will of the voters.”

Ferguson’s argument split on the issues. Included in his brief was a recounting of the AG’s assertion, previously stated in a January memo from his office, that localities do have the right to set zoning and other local rules.

“That authority comes directly from article XI, section 11 of the Washington Constitution, which provides that ‘[a]ny county, city, town or township may make and enforce within its limits all such local police, sanitary and other regulations as are not in conflict with general laws.’” Ferguson wrote.

On the question of federal preemption, the AG expressed his disagreement with Fife’s claim. Ferguson made his opinion clear that if the Court ruled against the ban in Fife, I-502 still holds up to judicial review. He argued that the federal Controlled Substances Act, or CSA, does not prohibit state marijuana laws.

The American Civil Liberties Union of Washington took up the case against the local bans a week after Ferguson intervened. The ACLU-WA received permission to file a brief on behalf of three state-licensed marijuana businesses. The interested parties, Downtown Cannabis Company in Pacific, Monkey Grass Farms in Chelan County and Rainier on Pine in Tacoma stated their intent to challenge similar marijuana business prohibitions.

Alison Holcomb, Criminal Justice Director for ACLU of WA, filed the brief. In it, she asserts that the assumption that localities may prohibit marijuana businesses “would completely block the implementation of the comprehensive regulatory scheme enacted by Initiative 502.”
Holcomb joined Ferguson in defense of the state law against “federal preemption.”

Fife argued that it can’t be forced to follow I-502 because federal drug laws prevent the state initiative. Holcomb retorted that, on the contrary, Congress specifically “saved state drug laws from preemption” by federal law in the Controlled Substances Act.

The day after the ACLU and the Attorney General filed their briefs, lawyers representing Pierce and Lewis counties, the city of Yakima and the town of Wilbur did the same. The other jurisdictions stated that they had a compelling interest in the case and argued in favor of Fife’s motion for summary judgment allowing the prohibition to stand.

“I-502 contains no express or implied intent to preempt the City’s plenary constitutional authority to regulate.” Lawyers said about the question of state preemption. “If this Court finds that state law preempts the city ordinance, it must move to federal law analysis,” which they say will invalidate I-502.

After all the briefs were filed, Judge Ronald Culpepper scheduled oral arguments for August 29 at 9am. The day before the hearing, Marijuana.com got some insight on the issue of federal preemption from Jim Doherty, a former drug prosecutor who now works with groups like Law Enforcement Against Prohibition.

“I’ve sat through a number of presentations about the federal preemption issue,” Doherty said in a phone interview. He shared his opinion that the federal government isn’t pressing the issue because it would be a close case.

Doherty said Fife could be an important test case about federal preemption, depending on “how it’s handled by the appellate court.” If Judge Culpepper brought the issue forward, it could create a legal mess for both state and federal governments.

The Department of Justice’s “Cole memo” allowing states to carry out their marijuana laws as long as they follow certain federal priorities has been crucial for the growth of cannabis. A court ruling to the contrary would render the memo useless as protection.

Unfortunately, Henery won’t be setting up his shop in Fife any time soon and neither will anyone else. After hearing oral arguments on August 29, Judge Culpepper denied MMH’s motion for summary judgement the same day and upheld the right of localities to disallow marijuana operations. While Culpepper stated that he would not directly address the federal preemption issue, he did mention his feelings on how he would have ruled.

“I think I am inclined to agree with the interveners that there is no federal preemption here. The statute itself grants the State quite a bit of authority. The Feds do not preempt the State’s authority to legislate in this area.” Judge Culpepper said.

2014-08-29 – Ruling on Motions for Summary Judgment

While the judge stated unequivocally that the purpose of his ruling was not to judge whether I-502 is good or bad, he did express his personal feelings about the law to some extent.

“It may be great legislation, maybe not so great, but it does set up what appears to me to be a fairly well thought-out, comprehensive system of licensing and regulation of marijuana production, processing, and retailing.”

Culpepper summed up the crux of the case, in his opinion, as being an issue of state goals in I-502 conflicting with municipal laws backed by the state’s constitution.

“The plaintiffs have apparently valid licenses issued by the Liquor Control Board, which is authorized to set up the regulatory scheme to suppress the black market, to raise taxes, all the good things Initiative 502 hopes to do, but Fife does not allow them to do their business within the borders of Fife.”

The judge concluded that the local rules do not “irreconcilably conflict with I-502.” With the burden of proof on the parties opposing Fife’s ban, this was enough to settle the issue without moving on to the federal preemption issue.

Marijuana.com caught up with Holcomb to get her opinion on what the ruling means for the future. She provided us with the following statement in an email:

“The ACLU of Washington disagrees with Judge Culpepper’s ruling on local bans, and the decision is likely to be appealed, but ultimately this issue should be put to rest by the legislature. Patchwork implementation will undercut the goal of undermining the black market and frustrate the will of the voters who passed Initiative 502. If the legislature nevertheless decides to allow cities or counties to ban licensed and regulated marijuana businesses, such bans should only be enacted by a vote of the local residents, the same way the Washington State Liquor Act allows for ‘dry counties.’”

With many localities in both Washington and Colorado prohibiting marijuana operations by zoning them out, these issues will continue to be considered and addressed on many levels. As for what marijuana businesses should do while the courts and legislature sort it out, Judge Culpepper had a suggestion.

“I think if I were going to set up a shop, I would do it right across the border.” Culpepper said.

Fife represents another battleground in the continuing War on Marijuana–in a state where weed is legal.

This article was originally published by Marijuana.com.

University of Colorado studying effect of medical marijuana on epilepsy

One of the more common cop-outs lawmakers make when approached about marijuana legalization occurs when legislators claim there “isn’t enough scientific evidence” regarding marijuana’s medicinal benefits. With more substantial studies and evidence about the true medical powers of marijuana, that point will lose any validity.

Now, the University of Colorado’s Anschutz Medical Campus aims to add another nail to prohibition’s coffin with a new clinical trial. The study will attempt to show a genetic reason for the efficacy of medical marijuana in treating a severe seizure disorder affecting children.

The University titled the study, “Genetic Analysis Between Charlotte’s Web Responders Versus Non-Responders in a Dravet Population” and they are currently in the process of gathering 150 patients who will make up the study group. Children affected by Dravet Syndrome have a genetic mutation causing dozens of seizures a day in cases like that ofCharlotte Figi.

Last year, CNN Medical Correspondent Dr. Sanjay Gupta profiled Charlotte and her parents’ fight against the debilitating disorder in a special called “WEED”. They told their story of how a strain of marijuana came to be named for Charlotte after it showed great success in preventing her seizures. Charlotte’s Web marijuana is turned into concentrated oil that can be taken by patients in the form of a pill.

Dr. Edward Maa, an assistant professor of medicine at the CU School of Medicine and chief of the Comprehensive Epilepsy Programs at Denver Health, recently explained the study’s importance.

“The more data we are able to collect in a large sample, the closer to the truth we will get,” says Maa. He says the study could allow children with Dravet Syndrome to be genetically screened before taking Charlotte’s Web so parents could know ahead of time if their children would benefit.

“Do you uproot and move your entire family to not have an effect? I think this could be very helpful to answer this question,” says Maa. [Time.com]

Rather than administering the marijuana compound to participants, Dr. Maa’s team will study the “genetic differences between patients” who have responded well to highly-concentrated CBD treatment and those who did not. He says that this could help determine what factors make marijuana an effective medical treatment; information that is sorely lacking.

Dr. Maa calls an interventional study with participants using the compound and researchers studying the effects directly “the Holy Grail.” Unfortunately, trail-blazers like Dr. Sue Sisley, formerly of the University of Arizona, highlight the red-tape nightmare that studies like that create. One that led to the loss of her job and research grant.

ClinicalTrials.gov, an online service provided by the U.S. National Institutes of Health, reveals that the University of Colorado is not the only organization studying the efficacy of CBD in treating Dravet Syndrome. GW Research Ltd has at least four studies in the works with the same goal, though they have not begun participant recruitment.

This article was originally published by Marijuana.com.

Rare Dankness and Elite Cannabis Launch Joint Venture

Have you ever wondered how the hundreds of strains of cannabis are created? Who is it that creates the different types of greenery with all the funny names? Driven individuals and companies strive to create the next big strain, the next award-winner, even the next disease cure. They are the cannabis breeders and consultants.

These mysterious cannabis experts stayed out of legal harm by congregating on chat boards during the ‘90s and many headed to Europe before that. Online communities helped cannabis pioneers share knowledge in hopes of making a better plant. As cannabis gains respect as a medicine, cannabis breeders and researchers join in knowledge and now industry.

Rare Dankness and Elite Cannabis, two such cannabis “genetics” companies, announced on July 24 that they will be joining forces to provide “premium products and services to the legal cannabis marketplace,” according to a press release.

The new company, known as Elite Dankness, will also bring in Kenneth Morrow, Founder of Trichome Technologies, and Green Man Cannabis, a Colorado cannabis dispensary chain. The release touts Morrow as the “author of more articles in High Times Magazine than any other contributor.” He will be acting as the company’s Chief Scientist.

This article was originally published by The Hemp Connoisseur Magazine as Skyler Cannabaceae.
The Hemp Connoisseur, September 2014 – Issue #21